Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

University of Calgary

$40,000.00

Dynamic effects of inflammatory cytokines on signaling and gene expression: Modulation and priming of epithelial cell responses

EF 2024-25

Résumé
BACKGROUND: This proposal forms the most recent part of a 2 decade-long programme investigating the transcription factor, nuclear factor (NF)-?B, and the regulation of gene expression by the inflammatory cytokine, interleukin (1L)-1ß. Classical NF-?B comprises of the Rel family members, p50 and p65, and is triggered via a "canonical" cascade involving the upstream kinase, TGFß-activated kinase 1 (TAK1). TAK1 activates the inhibitor of ?B (I?B) kinase (IKK) complex, which phosphorylates the inhibitor protein, I?Ba, and signals for its degradation. This allows nuclear translocation by p50/p65 to activate gene transcription. However, using pulmonary epithelial cells to model IL-1ß-induced signalling, recent data shows that the canonical pathway is insufficient for full NF-?B activity. Thus, in cells lacking TAK1, NF-?B activation is reduced, but not prevented. These novel data are supported by pharmacological inhibition of IKKß. This only partially reduces NF-?B activity and leads to hypothesis 1. HYPOTHESIS 1: In addition to the canonical TAK1-IKKß cascade, parallel pathways are necessary for full NF-?B activity. Our mRNA-sequencing data shows IL-1ß to upregulate expression of kinases, including various IL1 receptor-associated kinases (IRAKs), Rel family transcription factors and receptors. This leads to a further hypothesis. HYPOTHESIS 2: Induced expression of kinases, receptors and transcription factors constitutes new signalling pathways that lead to distinct downstream responses and/or primes cells to new stimuli. AIMS: To address these hypotheses, A549 pulmonary epithelial cells provide a robust platform in which we characterised all the genes responding to IL-1ß and all the genomic p65/NF-?B genomic binding sites. Three main research aims are proposed and will be validated in primary cells: 1. To define the canonical TAK1-IKK pathway in the activation of NF-?B and then explore roles for parallel non-TAK1, non-IKKß pathways. 2. To explore the effects of IL-1ß-induced IRAK expression in the activation of NF-?B. 3. To investigate the ability of IL-1ß-induced gene products to constitute new signalling pathways and prime for new responses. OUTCOMES: Alternative NF-?B signalling and the temporal control of signal transduction is underexplored, yet ripe for investigation. Here, expression and genomic data is integrated into a dynamic framework for the control of signalling and gene expression by NF-?B. Understanding this priming of epithelial cells will allow elucidation of novel roles in inflammation and host defence. The programme provides extensive wet-lab and informatics learning opportunities for a diverse group of trainees who are encouraged to work co-operatively. This builds technical skills and will enable novel discoveries. The development of teaching and training skills, along with logic, critical thinking and other transferable skills, ensures that each trainee is positioned for success in academic and non-academic workplaces.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
RGPIN-2023-03763
Name nom
Newton, Robert
Department département
Physiology and Pharmacology
Organization id
11
Institution établissement
University of Calgary
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2023
Award amount
40000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5300
Research subject group en
Molecular biology
Research subject group fr
Biologie moléculaire
Research subject en
Molecular biology
Research subject fr
Biologie moléculaire
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Dynamic effects of inflammatory cytokines on signaling and gene expression: Modulation and priming of epithelial cell responses
Keywords
signaling; gene regulation; cytokines; epithelial cell; inflammation; gene expression; transcription; nf-kappab
Application summary
BACKGROUND: This proposal forms the most recent part of a 2 decade-long programme investigating the transcription factor, nuclear factor (NF)-?B, and the regulation of gene expression by the inflammatory cytokine, interleukin (1L)-1ß. Classical NF-?B comprises of the Rel family members, p50 and p65, and is triggered via a "canonical" cascade involving the upstream kinase, TGFß-activated kinase 1 (TAK1). TAK1 activates the inhibitor of ?B (I?B) kinase (IKK) complex, which phosphorylates the inhibitor protein, I?Ba, and signals for its degradation. This allows nuclear translocation by p50/p65 to activate gene transcription. However, using pulmonary epithelial cells to model IL-1ß-induced signalling, recent data shows that the canonical pathway is insufficient for full NF-?B activity. Thus, in cells lacking TAK1, NF-?B activation is reduced, but not prevented. These novel data are supported by pharmacological inhibition of IKKß. This only partially reduces NF-?B activity and leads to hypothesis 1. HYPOTHESIS 1: In addition to the canonical TAK1-IKKß cascade, parallel pathways are necessary for full NF-?B activity. Our mRNA-sequencing data shows IL-1ß to upregulate expression of kinases, including various IL1 receptor-associated kinases (IRAKs), Rel family transcription factors and receptors. This leads to a further hypothesis. HYPOTHESIS 2: Induced expression of kinases, receptors and transcription factors constitutes new signalling pathways that lead to distinct downstream responses and/or primes cells to new stimuli. AIMS: To address these hypotheses, A549 pulmonary epithelial cells provide a robust platform in which we characterised all the genes responding to IL-1ß and all the genomic p65/NF-?B genomic binding sites. Three main research aims are proposed and will be validated in primary cells: 1. To define the canonical TAK1-IKK pathway in the activation of NF-?B and then explore roles for parallel non-TAK1, non-IKKß pathways. 2. To explore the effects of IL-1ß-induced IRAK expression in the activation of NF-?B. 3. To investigate the ability of IL-1ß-induced gene products to constitute new signalling pathways and prime for new responses. OUTCOMES: Alternative NF-?B signalling and the temporal control of signal transduction is underexplored, yet ripe for investigation. Here, expression and genomic data is integrated into a dynamic framework for the control of signalling and gene expression by NF-?B. Understanding this priming of epithelial cells will allow elucidation of novel roles in inflammation and host defence. The programme provides extensive wet-lab and informatics learning opportunities for a diverse group of trainees who are encouraged to work co-operatively. This builds technical skills and will enable novel discoveries. The development of teaching and training skills, along with logic, critical thinking and other transferable skills, ensures that each trainee is positioned for success in academic and non-academic workplaces.